(Q38433416)

3 September 2017

title

Substantial changes in prescription recommendations for bipolar disorder in Canada: 2002-2010. (English)

1 reference

3 September 2017

1 reference

1 reference

Andrew G M Bulloch

1

1 reference

3 September 2017

Lauren C Bresee

series ordinal

2

1 reference

3 September 2017

Cynthia A Beck

series ordinal

3

1 reference

3 September 2017

Scott B Patten

series ordinal

4

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 April 2012

1 reference

Canadian Journal of Psychiatry

3 September 2017

published in

1 reference

3 September 2017

volume

57

1 reference

3 September 2017

issue

4

1 reference

3 September 2017

page(s)

263-268

1 reference

The bipolar spectrum--the shaping of a new paradigm in psychiatry

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700410

A new bipolar spectrum concept: a brief review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700410

"Cade's disease" and beyond: misdiagnosis, antidepressant use, and a proposed definition for bipolar spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700410

The history of lithium therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700410

A critical appraisal of lithium's efficacy and effectiveness: the last 60 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700410

Lithium specificity in bipolar illness: a classic agent for the classic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700410

Are antidepressants safe in the treatment of bipolar depression? A critical evaluation of their potential risk to induce switch into mania or cycle acceleration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700410

Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700410

Anticonvulsants in bipolar disorders: current research and practice and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700410

Antipsychotic agents in the treatment of bipolar mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700410

The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700410

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700410

Extending indications for long-term pharmacotherapy: opportunities and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700410

Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700410

Relationship of pharmaceutical promotion to antidepressant switching and adherence: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700410

Increased rates of bipolar disorder diagnoses among U.S. child, adolescent, and adult inpatients, 1996-2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700410

Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700410

Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700410

Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700410

10.1177/070674371205700410

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference